Virtu Financial LLC Nu Cana PLC Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024
BUY
$0.26 - $0.8 $5,260 - $16,186
20,233 New
20,233 $6,000
Q1 2023

May 01, 2023
BUY
$0.76 - $1.69 $7,729 - $17,188
10,171 Added 70.59%
24,580 $24,000
Q4 2022

Feb 15, 2023
BUY
$0.66 - $27.41 $9,509 - $394,950
14,409 New
14,409 $10,000
Q2 2022

Aug 09, 2022
SELL
$0.59 - $1.06 $36,680 - $65,900
-62,170 Reduced 79.75%
15,782 $11,000
Q1 2022

May 17, 2022
BUY
$0.74 - $3.27 $36,145 - $159,723
48,845 Added 167.81%
77,952 $78,000
Q4 2021

Feb 17, 2022
BUY
$2.02 - $2.9 $58,796 - $84,410
29,107 New
29,107 $69,000

Others Institutions Holding NCNA

# of Institutions
1
Shares Held
3.33M
Call Options Held
0
Put Options Held
0
View Full List

About NuCana plc

NCNA Quotes by TradingView
  • Ticker NCNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,196,000
  • Market Cap $69.9M
  • Description
  • NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...
More about NCNA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email